JNJ SEC Filings
SEC filings for JNJ. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 8-K | Oct 13, 2026 | 0000200406-26-000189EDGAR |
| 8-KAIJohnson & Johnson announced that Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee, will retire effective September 1, 2026. | Aug 4, 2026 | 0000200406-26-000167EDGAR |
| 8-K | Jul 29, 2026 | 0000200406-26-000163EDGAR |
| 8-K | Jul 28, 2026 | 0000200406-26-000155EDGAR |
| 8-KAIJohnson & Johnson filed an 8-K disclosing its second quarter 2026 sales and earnings results for the period ended June 28, 2026, via an attached press release and supplementary financial data. | Jul 15, 2026 | 0000200406-26-000146EDGAR |
| 8-K | Apr 27, 2026 | 0000200406-26-000089EDGAR |
| 8-K | Apr 14, 2026 | 0000200406-26-000076EDGAR |
| 8-K | Jan 21, 2026 | 0000200406-26-000002EDGAR |
SEC filings for companies related to JNJ
Never miss a JNJ filing.
Get an email when JNJ files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.